Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiomyopathy, Hypertrophic | 52 | 2024 | 1335 | 6.950 |
Why?
|
Heart Septum | 10 | 2021 | 304 | 2.020 |
Why?
|
Ethanol | 7 | 2023 | 1333 | 0.970 |
Why?
|
Ventricular Outflow Obstruction | 4 | 2023 | 262 | 0.950 |
Why?
|
Cardiac Surgical Procedures | 9 | 2023 | 3681 | 0.950 |
Why?
|
Myocardial Contraction | 19 | 2001 | 1527 | 0.720 |
Why?
|
Hypertrophy, Left Ventricular | 5 | 2024 | 856 | 0.650 |
Why?
|
Ablation Techniques | 2 | 2019 | 255 | 0.640 |
Why?
|
Solvents | 2 | 2018 | 298 | 0.630 |
Why?
|
Blood Proteins | 5 | 2024 | 1186 | 0.610 |
Why?
|
Heart Failure | 30 | 2024 | 11860 | 0.600 |
Why?
|
Nitroprusside | 15 | 2001 | 272 | 0.600 |
Why?
|
Sclerosing Solutions | 3 | 2006 | 79 | 0.590 |
Why?
|
Proteomics | 8 | 2024 | 3906 | 0.560 |
Why?
|
Hemodynamics | 27 | 2019 | 4199 | 0.480 |
Why?
|
Atrial Natriuretic Factor | 6 | 1994 | 350 | 0.450 |
Why?
|
Heart Valve Prosthesis Implantation | 4 | 2019 | 1568 | 0.440 |
Why?
|
Diastole | 11 | 1994 | 784 | 0.430 |
Why?
|
Metabolome | 1 | 2020 | 1008 | 0.420 |
Why?
|
Losartan | 1 | 2013 | 263 | 0.390 |
Why?
|
Echocardiography | 12 | 2024 | 5044 | 0.370 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 429 | 0.360 |
Why?
|
Metabolomics | 1 | 2020 | 1675 | 0.360 |
Why?
|
Atrioventricular Block | 2 | 2023 | 141 | 0.320 |
Why?
|
Predictive Value of Tests | 8 | 2024 | 15455 | 0.310 |
Why?
|
Mitral Valve | 4 | 2019 | 1474 | 0.280 |
Why?
|
Aortic Valve Insufficiency | 1 | 2011 | 577 | 0.280 |
Why?
|
Sinus of Valsalva | 1 | 2007 | 60 | 0.270 |
Why?
|
Cardiac Tamponade | 2 | 2006 | 175 | 0.270 |
Why?
|
Heart Ventricles | 11 | 2023 | 3838 | 0.270 |
Why?
|
Nicardipine | 3 | 1991 | 60 | 0.260 |
Why?
|
Pericardiocentesis | 1 | 2006 | 78 | 0.260 |
Why?
|
Ventricular Dysfunction, Left | 3 | 2006 | 2144 | 0.250 |
Why?
|
Coronary Disease | 8 | 2002 | 5926 | 0.240 |
Why?
|
Myocardium | 5 | 2021 | 4788 | 0.240 |
Why?
|
Sclerotherapy | 1 | 2006 | 183 | 0.240 |
Why?
|
Mitral Valve Stenosis | 2 | 2002 | 342 | 0.240 |
Why?
|
Animals, Domestic | 1 | 2004 | 56 | 0.230 |
Why?
|
Cat Diseases | 1 | 2004 | 32 | 0.230 |
Why?
|
Exercise | 2 | 2020 | 5947 | 0.230 |
Why?
|
Heart | 8 | 2022 | 4449 | 0.230 |
Why?
|
Heart Block | 1 | 2005 | 390 | 0.220 |
Why?
|
Stroke Volume | 13 | 2024 | 5620 | 0.220 |
Why?
|
Sequoia | 1 | 2023 | 6 | 0.220 |
Why?
|
Ferricyanides | 3 | 1989 | 31 | 0.220 |
Why?
|
Coronary Vessels | 4 | 2015 | 3125 | 0.220 |
Why?
|
Aortic Rupture | 1 | 2007 | 322 | 0.220 |
Why?
|
Humans | 117 | 2024 | 768298 | 0.220 |
Why?
|
Ancillary Services, Hospital | 1 | 2002 | 23 | 0.210 |
Why?
|
Death, Sudden, Cardiac | 4 | 2024 | 1568 | 0.210 |
Why?
|
Aortic Aneurysm | 2 | 2007 | 649 | 0.210 |
Why?
|
Middle Aged | 66 | 2024 | 223463 | 0.210 |
Why?
|
Aortic Valve Stenosis | 8 | 2024 | 2034 | 0.200 |
Why?
|
Gadolinium | 2 | 2024 | 965 | 0.200 |
Why?
|
Pulmonary Wedge Pressure | 4 | 2018 | 275 | 0.200 |
Why?
|
Adipokines | 1 | 2024 | 309 | 0.190 |
Why?
|
Cardiac Pacing, Artificial | 4 | 2012 | 881 | 0.190 |
Why?
|
Tricuspid Valve Stenosis | 1 | 2001 | 26 | 0.190 |
Why?
|
Coronary Angiography | 6 | 2020 | 4537 | 0.190 |
Why?
|
Coronary Care Units | 1 | 2002 | 235 | 0.180 |
Why?
|
Utilization Review | 1 | 2002 | 384 | 0.180 |
Why?
|
Aged | 50 | 2024 | 171544 | 0.180 |
Why?
|
Informed Consent | 1 | 2007 | 1010 | 0.180 |
Why?
|
Systole | 12 | 1998 | 937 | 0.180 |
Why?
|
Male | 73 | 2024 | 364870 | 0.180 |
Why?
|
Contrast Media | 2 | 2024 | 5337 | 0.180 |
Why?
|
Disopyramide | 2 | 2023 | 16 | 0.180 |
Why?
|
Cardiac Output, Low | 2 | 1992 | 191 | 0.180 |
Why?
|
Norepinephrine | 4 | 2019 | 900 | 0.170 |
Why?
|
Case-Control Studies | 8 | 2024 | 22292 | 0.170 |
Why?
|
Ventricular Function, Left | 6 | 2024 | 3942 | 0.170 |
Why?
|
American Heart Association | 4 | 2011 | 1051 | 0.170 |
Why?
|
Blood Volume | 3 | 1990 | 545 | 0.160 |
Why?
|
Female | 68 | 2024 | 397050 | 0.160 |
Why?
|
Unnecessary Procedures | 1 | 2002 | 419 | 0.160 |
Why?
|
Pacemaker, Artificial | 3 | 2018 | 828 | 0.160 |
Why?
|
Cardiovascular Agents | 2 | 2020 | 849 | 0.160 |
Why?
|
Angioplasty, Balloon, Coronary | 3 | 2012 | 1724 | 0.160 |
Why?
|
Least-Squares Analysis | 1 | 2019 | 368 | 0.160 |
Why?
|
Exercise Test | 3 | 2021 | 2186 | 0.150 |
Why?
|
Myocardial Infarction | 5 | 2016 | 11515 | 0.150 |
Why?
|
Bioprosthesis | 1 | 2002 | 592 | 0.150 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2024 | 1092 | 0.140 |
Why?
|
Diagnostic Tests, Routine | 1 | 2002 | 790 | 0.140 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2001 | 362 | 0.130 |
Why?
|
Cause of Death | 3 | 2024 | 3728 | 0.130 |
Why?
|
Cardiotonic Agents | 5 | 1992 | 544 | 0.130 |
Why?
|
Electrocardiography | 3 | 2008 | 6409 | 0.130 |
Why?
|
Coronary Artery Disease | 3 | 2020 | 6566 | 0.130 |
Why?
|
Iatrogenic Disease | 1 | 2019 | 552 | 0.130 |
Why?
|
Alcohols | 1 | 2016 | 94 | 0.130 |
Why?
|
Vasodilator Agents | 5 | 1998 | 990 | 0.120 |
Why?
|
Epinephrine | 1 | 2019 | 795 | 0.120 |
Why?
|
Adult | 39 | 2024 | 223622 | 0.120 |
Why?
|
Aptamers, Nucleotide | 1 | 2016 | 162 | 0.120 |
Why?
|
Stents | 2 | 2004 | 3201 | 0.120 |
Why?
|
Dobutamine | 2 | 1992 | 116 | 0.120 |
Why?
|
Echocardiography, Doppler | 4 | 2011 | 899 | 0.110 |
Why?
|
Blood Pressure | 13 | 2004 | 8541 | 0.110 |
Why?
|
Decision Support Techniques | 2 | 2024 | 2005 | 0.110 |
Why?
|
Computers, Handheld | 1 | 2015 | 211 | 0.110 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 937 | 0.110 |
Why?
|
Nifedipine | 3 | 2001 | 220 | 0.110 |
Why?
|
Heart Valve Prosthesis | 3 | 2019 | 1468 | 0.110 |
Why?
|
Ventricular Function | 3 | 2008 | 406 | 0.100 |
Why?
|
Dyspnea | 2 | 2015 | 1351 | 0.100 |
Why?
|
Shock | 2 | 2006 | 316 | 0.100 |
Why?
|
Prospective Studies | 11 | 2024 | 54921 | 0.100 |
Why?
|
Exercise Therapy | 1 | 2019 | 941 | 0.100 |
Why?
|
Catheter Ablation | 4 | 2017 | 2776 | 0.100 |
Why?
|
Heart Valve Diseases | 1 | 2019 | 1031 | 0.090 |
Why?
|
Pressure | 4 | 2006 | 1172 | 0.090 |
Why?
|
Peptide Mapping | 1 | 2011 | 259 | 0.090 |
Why?
|
Bundle-Branch Block | 1 | 2013 | 278 | 0.090 |
Why?
|
Imidazoles | 2 | 1987 | 1168 | 0.090 |
Why?
|
Models, Genetic | 1 | 2021 | 3442 | 0.090 |
Why?
|
Calcium Channel Blockers | 2 | 2012 | 692 | 0.090 |
Why?
|
Coronary Artery Bypass | 1 | 2020 | 2194 | 0.090 |
Why?
|
Referral and Consultation | 2 | 2015 | 3627 | 0.090 |
Why?
|
Anesthesia, Epidural | 1 | 2013 | 232 | 0.090 |
Why?
|
Ventricular Septum | 2 | 2008 | 76 | 0.090 |
Why?
|
Nitric Oxide | 2 | 2001 | 2143 | 0.090 |
Why?
|
Cardiology Service, Hospital | 1 | 2012 | 242 | 0.090 |
Why?
|
Risk Factors | 13 | 2024 | 74954 | 0.080 |
Why?
|
Treatment Outcome | 9 | 2024 | 65365 | 0.080 |
Why?
|
Blood Chemical Analysis | 1 | 2011 | 436 | 0.080 |
Why?
|
Heart Function Tests | 1 | 1990 | 318 | 0.080 |
Why?
|
Aged, 80 and over | 13 | 2021 | 59683 | 0.080 |
Why?
|
Anabolic Agents | 1 | 2011 | 256 | 0.080 |
Why?
|
Cardiovascular Diseases | 2 | 2021 | 15652 | 0.080 |
Why?
|
Patient Care Team | 1 | 2020 | 2529 | 0.080 |
Why?
|
Chest Pain | 1 | 2015 | 1099 | 0.080 |
Why?
|
Tomography, Emission-Computed | 1 | 1991 | 1126 | 0.080 |
Why?
|
Treatment Failure | 2 | 2006 | 2664 | 0.080 |
Why?
|
Vascular Surgical Procedures | 1 | 2017 | 1515 | 0.080 |
Why?
|
Drug Administration Schedule | 2 | 2013 | 4859 | 0.070 |
Why?
|
Heart Diseases | 4 | 2015 | 2819 | 0.070 |
Why?
|
Atrial Fibrillation | 2 | 2024 | 5168 | 0.070 |
Why?
|
Genetic Testing | 1 | 2021 | 3587 | 0.070 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2008 | 109 | 0.070 |
Why?
|
Cardiac Output | 3 | 1991 | 838 | 0.070 |
Why?
|
Fabry Disease | 1 | 2008 | 89 | 0.070 |
Why?
|
Tachycardia | 1 | 1989 | 598 | 0.070 |
Why?
|
Natriuretic Peptide, Brain | 3 | 2024 | 1751 | 0.070 |
Why?
|
MicroRNAs | 1 | 2023 | 3794 | 0.070 |
Why?
|
Aortic Valve | 3 | 1992 | 1970 | 0.070 |
Why?
|
Quinolines | 1 | 1992 | 768 | 0.070 |
Why?
|
Magnetic Resonance Angiography | 1 | 2013 | 1434 | 0.070 |
Why?
|
Anti-Infective Agents, Local | 1 | 2009 | 248 | 0.070 |
Why?
|
Health Status | 2 | 2020 | 4094 | 0.070 |
Why?
|
Tachycardia, Sinus | 1 | 2006 | 43 | 0.070 |
Why?
|
Heart Injuries | 1 | 2008 | 207 | 0.070 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2012 | 1244 | 0.070 |
Why?
|
Genotype | 1 | 2021 | 13038 | 0.070 |
Why?
|
Patient Selection | 1 | 2018 | 4265 | 0.070 |
Why?
|
Ventricular Fibrillation | 1 | 2009 | 537 | 0.070 |
Why?
|
Fibrosis | 1 | 2013 | 2076 | 0.070 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 1987 | 213 | 0.070 |
Why?
|
Cats | 2 | 2004 | 978 | 0.070 |
Why?
|
Creatine Kinase | 2 | 2004 | 685 | 0.070 |
Why?
|
Peptide Fragments | 3 | 2024 | 5151 | 0.070 |
Why?
|
Cardiomyopathies | 2 | 2024 | 2056 | 0.060 |
Why?
|
Hemangiosarcoma | 1 | 1988 | 216 | 0.060 |
Why?
|
Anesthesia, General | 1 | 2013 | 1186 | 0.060 |
Why?
|
Enoximone | 3 | 1993 | 9 | 0.060 |
Why?
|
Injections, Intralesional | 1 | 2006 | 280 | 0.060 |
Why?
|
Prognosis | 8 | 2024 | 30020 | 0.060 |
Why?
|
Vascular Resistance | 4 | 1994 | 940 | 0.060 |
Why?
|
Natriuretic Peptides | 1 | 2006 | 156 | 0.060 |
Why?
|
Boston | 4 | 2020 | 9371 | 0.060 |
Why?
|
Heart Neoplasms | 1 | 1988 | 374 | 0.060 |
Why?
|
Follow-Up Studies | 7 | 2023 | 39405 | 0.060 |
Why?
|
Abscess | 1 | 2008 | 606 | 0.060 |
Why?
|
Cardiology | 1 | 2015 | 1701 | 0.060 |
Why?
|
Creatine Kinase, MB Form | 1 | 2004 | 202 | 0.060 |
Why?
|
Heart Atria | 2 | 2007 | 1360 | 0.060 |
Why?
|
Syncope | 2 | 2005 | 430 | 0.060 |
Why?
|
Mass Spectrometry | 1 | 2011 | 2201 | 0.060 |
Why?
|
Risk Assessment | 5 | 2024 | 24316 | 0.060 |
Why?
|
Retrospective Studies | 12 | 2024 | 81768 | 0.060 |
Why?
|
Medical Oncology | 1 | 2015 | 2348 | 0.050 |
Why?
|
Neurosecretory Systems | 1 | 1985 | 223 | 0.050 |
Why?
|
Heart Murmurs | 1 | 2003 | 92 | 0.050 |
Why?
|
Catheterization | 1 | 1988 | 1431 | 0.050 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2023 | 775 | 0.050 |
Why?
|
Mitral Valve Insufficiency | 2 | 2007 | 1414 | 0.050 |
Why?
|
Angina Pectoris | 1 | 1986 | 960 | 0.050 |
Why?
|
Safety | 1 | 2007 | 1159 | 0.050 |
Why?
|
Gated Blood-Pool Imaging | 2 | 1992 | 44 | 0.050 |
Why?
|
Coronary Stenosis | 1 | 2008 | 802 | 0.050 |
Why?
|
Aortic Diseases | 1 | 2008 | 742 | 0.050 |
Why?
|
Time Factors | 8 | 2024 | 40267 | 0.050 |
Why?
|
Forms and Records Control | 1 | 2002 | 158 | 0.050 |
Why?
|
Pilot Projects | 2 | 2013 | 8730 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 2 | 2009 | 2258 | 0.050 |
Why?
|
Cardiomyopathy, Dilated | 3 | 1998 | 843 | 0.050 |
Why?
|
Amyloid Neuropathies, Familial | 1 | 2024 | 180 | 0.050 |
Why?
|
Software | 1 | 2015 | 4452 | 0.050 |
Why?
|
Infusions, Intravenous | 3 | 2001 | 2226 | 0.050 |
Why?
|
Surgical Procedures, Operative | 1 | 2013 | 1937 | 0.050 |
Why?
|
Isoenzymes | 3 | 2004 | 1684 | 0.050 |
Why?
|
Blood Gas Analysis | 1 | 2002 | 384 | 0.050 |
Why?
|
Total Quality Management | 1 | 2002 | 265 | 0.050 |
Why?
|
Choice Behavior | 1 | 2007 | 848 | 0.050 |
Why?
|
Proteome | 1 | 2011 | 1880 | 0.050 |
Why?
|
Signal Transduction | 4 | 2024 | 23629 | 0.040 |
Why?
|
Practice Guidelines as Topic | 2 | 2011 | 7453 | 0.040 |
Why?
|
Japan | 1 | 2024 | 1418 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2006 | 2862 | 0.040 |
Why?
|
Tachycardia, Ventricular | 1 | 2009 | 1309 | 0.040 |
Why?
|
Postoperative Complications | 2 | 2001 | 15854 | 0.040 |
Why?
|
Blood Flow Velocity | 4 | 1994 | 1375 | 0.040 |
Why?
|
Diagnosis, Differential | 5 | 2024 | 13019 | 0.040 |
Why?
|
Troponin T | 1 | 2004 | 787 | 0.040 |
Why?
|
Oxygen Consumption | 2 | 2021 | 1882 | 0.040 |
Why?
|
Biopsy | 1 | 2011 | 6808 | 0.040 |
Why?
|
Pyridones | 4 | 1986 | 818 | 0.040 |
Why?
|
Societies, Medical | 4 | 2011 | 3960 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2013 | 12457 | 0.040 |
Why?
|
Pulmonary Ventilation | 1 | 2021 | 376 | 0.040 |
Why?
|
New York | 1 | 2021 | 884 | 0.040 |
Why?
|
Heart Rate | 4 | 2019 | 4218 | 0.040 |
Why?
|
Hospitals, Teaching | 1 | 2002 | 1155 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2024 | 10776 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2006 | 6238 | 0.040 |
Why?
|
Reoperation | 2 | 2003 | 4340 | 0.040 |
Why?
|
Disease Management | 1 | 2008 | 2536 | 0.030 |
Why?
|
Death | 1 | 2021 | 683 | 0.030 |
Why?
|
Cardiomegaly | 3 | 1985 | 591 | 0.030 |
Why?
|
Ventricular Function, Right | 1 | 2001 | 628 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2023 | 9508 | 0.030 |
Why?
|
Administration, Inhalation | 2 | 2001 | 1169 | 0.030 |
Why?
|
Heart Transplantation | 2 | 2024 | 3300 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2017 | 36849 | 0.030 |
Why?
|
Cohort Studies | 4 | 2024 | 41791 | 0.030 |
Why?
|
Intensive Care Units | 2 | 2006 | 3800 | 0.030 |
Why?
|
Prosthesis Design | 1 | 2002 | 2126 | 0.030 |
Why?
|
Acute Disease | 3 | 2021 | 7242 | 0.030 |
Why?
|
Workflow | 1 | 2020 | 859 | 0.030 |
Why?
|
Recurrence | 2 | 2008 | 8501 | 0.030 |
Why?
|
Stress, Mechanical | 1 | 1979 | 1679 | 0.030 |
Why?
|
DNA, Single-Stranded | 1 | 2016 | 352 | 0.030 |
Why?
|
Kidney | 1 | 1990 | 7063 | 0.030 |
Why?
|
Hypertension | 1 | 1994 | 8615 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2020 | 937 | 0.030 |
Why?
|
Atrial Function | 1 | 1994 | 99 | 0.030 |
Why?
|
Program Evaluation | 1 | 2002 | 2505 | 0.030 |
Why?
|
Propensity Score | 1 | 2021 | 1955 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1603 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3622 | 0.030 |
Why?
|
United States | 6 | 2019 | 73144 | 0.030 |
Why?
|
Critical Illness | 1 | 2006 | 2755 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2020 | 1515 | 0.030 |
Why?
|
Ultrasonography | 2 | 2005 | 6001 | 0.030 |
Why?
|
Mathematical Computing | 1 | 1992 | 142 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2016 | 997 | 0.030 |
Why?
|
Pulmonary Circulation | 1 | 1994 | 744 | 0.020 |
Why?
|
Vasoconstriction | 1 | 1994 | 594 | 0.020 |
Why?
|
Algorithms | 1 | 2012 | 14154 | 0.020 |
Why?
|
Critical Care | 1 | 2004 | 2716 | 0.020 |
Why?
|
Atrial Function, Right | 1 | 1991 | 32 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2016 | 20224 | 0.020 |
Why?
|
Lisinopril | 1 | 2011 | 60 | 0.020 |
Why?
|
Radiography | 1 | 2002 | 6993 | 0.020 |
Why?
|
Hospitals, General | 1 | 2015 | 807 | 0.020 |
Why?
|
Phenotype | 2 | 2021 | 16716 | 0.020 |
Why?
|
Furosemide | 1 | 2011 | 171 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2021 | 2784 | 0.020 |
Why?
|
Myocardial Reperfusion | 1 | 1991 | 339 | 0.020 |
Why?
|
Natriuresis | 1 | 1990 | 105 | 0.020 |
Why?
|
Mortality | 1 | 2021 | 2917 | 0.020 |
Why?
|
Adolescent | 4 | 2006 | 89182 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2016 | 1197 | 0.020 |
Why?
|
Registries | 2 | 2019 | 8378 | 0.020 |
Why?
|
Hypertension, Pulmonary | 1 | 2001 | 1597 | 0.020 |
Why?
|
Survival Analysis | 4 | 2009 | 10117 | 0.020 |
Why?
|
Actuarial Analysis | 1 | 1989 | 372 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 1998 | 1238 | 0.020 |
Why?
|
Systems Integration | 1 | 2011 | 430 | 0.020 |
Why?
|
Observer Variation | 1 | 2015 | 2623 | 0.020 |
Why?
|
Exercise Tolerance | 1 | 1994 | 848 | 0.020 |
Why?
|
Cardiomyopathy, Restrictive | 1 | 1989 | 61 | 0.020 |
Why?
|
Catecholamines | 1 | 1989 | 390 | 0.020 |
Why?
|
Isotopes | 1 | 2008 | 125 | 0.020 |
Why?
|
Survival Rate | 2 | 2001 | 12870 | 0.020 |
Why?
|
Emergency Treatment | 1 | 2012 | 496 | 0.020 |
Why?
|
Diuretics | 1 | 2011 | 612 | 0.020 |
Why?
|
Infusions, Parenteral | 1 | 1988 | 397 | 0.020 |
Why?
|
Coronary Sinus | 1 | 2008 | 85 | 0.020 |
Why?
|
Coronary Circulation | 2 | 1998 | 1617 | 0.020 |
Why?
|
Lactates | 1 | 1988 | 401 | 0.020 |
Why?
|
Advisory Committees | 1 | 2011 | 797 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2002 | 4339 | 0.020 |
Why?
|
Elasticity | 1 | 1989 | 657 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2001 | 5367 | 0.020 |
Why?
|
Neoplasms | 1 | 2015 | 22389 | 0.020 |
Why?
|
Rheology | 1 | 1987 | 348 | 0.020 |
Why?
|
Nitroglycerin | 1 | 1987 | 332 | 0.020 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2007 | 353 | 0.020 |
Why?
|
Data Collection | 1 | 2015 | 3324 | 0.020 |
Why?
|
Internal Mammary-Coronary Artery Anastomosis | 1 | 1986 | 38 | 0.020 |
Why?
|
Renin | 1 | 1988 | 648 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 1998 | 4427 | 0.020 |
Why?
|
Jogging | 1 | 2005 | 18 | 0.020 |
Why?
|
Drug Evaluation | 1 | 1987 | 642 | 0.020 |
Why?
|
Sotalol | 1 | 2005 | 47 | 0.020 |
Why?
|
Debridement | 1 | 2008 | 492 | 0.020 |
Why?
|
Metoprolol | 1 | 2005 | 90 | 0.020 |
Why?
|
Regression Analysis | 1 | 1994 | 6350 | 0.010 |
Why?
|
Reference Standards | 1 | 2008 | 1013 | 0.010 |
Why?
|
Models, Cardiovascular | 1 | 1990 | 984 | 0.010 |
Why?
|
Milrinone | 4 | 1986 | 86 | 0.010 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2011 | 1517 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2015 | 5311 | 0.010 |
Why?
|
Pericardium | 1 | 1989 | 679 | 0.010 |
Why?
|
Prevalence | 1 | 2021 | 15868 | 0.010 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2004 | 86 | 0.010 |
Why?
|
Aldosterone | 1 | 1988 | 881 | 0.010 |
Why?
|
Unconsciousness | 1 | 2005 | 251 | 0.010 |
Why?
|
Acute Coronary Syndrome | 1 | 2016 | 2192 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9681 | 0.010 |
Why?
|
Postoperative Period | 1 | 1987 | 1830 | 0.010 |
Why?
|
Kinetics | 2 | 2008 | 6334 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10844 | 0.010 |
Why?
|
Administration, Sublingual | 1 | 2001 | 60 | 0.010 |
Why?
|
Vasodilation | 2 | 2001 | 968 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14736 | 0.010 |
Why?
|
Logistic Models | 1 | 2015 | 13323 | 0.010 |
Why?
|
Aorta | 1 | 2008 | 2046 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14783 | 0.010 |
Why?
|
Dogs | 1 | 1985 | 3846 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 3707 | 0.010 |
Why?
|
Glucose | 1 | 1991 | 4354 | 0.010 |
Why?
|
Myocytes, Cardiac | 1 | 2008 | 1683 | 0.010 |
Why?
|
Defibrillators, Implantable | 1 | 2009 | 1498 | 0.010 |
Why?
|
Chronic Disease | 1 | 1994 | 9380 | 0.010 |
Why?
|
Animals | 5 | 2008 | 169322 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2008 | 4834 | 0.010 |
Why?
|
Erythrocyte Aging | 1 | 1979 | 53 | 0.010 |
Why?
|
Radionuclide Imaging | 3 | 1989 | 1998 | 0.010 |
Why?
|
Preoperative Care | 1 | 1987 | 2257 | 0.010 |
Why?
|
Infusions, Intra-Arterial | 1 | 1998 | 221 | 0.010 |
Why?
|
Laser-Doppler Flowmetry | 1 | 1998 | 238 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15939 | 0.010 |
Why?
|
Erythrocyte Membrane | 1 | 1979 | 438 | 0.010 |
Why?
|
Sympathetic Nervous System | 1 | 1979 | 521 | 0.010 |
Why?
|
Acetylcholine | 1 | 1998 | 629 | 0.010 |
Why?
|
Hemin | 1 | 1975 | 51 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1986 | 3781 | 0.010 |
Why?
|
Erythrocytes | 2 | 1989 | 2421 | 0.010 |
Why?
|
Radionuclide Angiography | 1 | 1994 | 23 | 0.010 |
Why?
|
Reticulocytes | 1 | 1975 | 288 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2009 | 12557 | 0.010 |
Why?
|
Heme | 1 | 1975 | 316 | 0.010 |
Why?
|
Adenosine | 1 | 1998 | 816 | 0.010 |
Why?
|
Stress, Psychological | 1 | 1989 | 4543 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2008 | 19019 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13696 | 0.010 |
Why?
|
Rats | 1 | 2008 | 23833 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 60048 | 0.010 |
Why?
|
Pericardial Effusion | 1 | 1994 | 246 | 0.010 |
Why?
|
Cyclic AMP | 1 | 1975 | 1468 | 0.010 |
Why?
|
Massachusetts | 1 | 2004 | 8902 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2004 | 12092 | 0.010 |
Why?
|
Protein Kinases | 1 | 1975 | 1609 | 0.000 |
Why?
|
Technetium | 1 | 1989 | 326 | 0.000 |
Why?
|
Protein Biosynthesis | 1 | 1975 | 2094 | 0.000 |
Why?
|
Age Factors | 1 | 1985 | 18472 | 0.000 |
Why?
|
Drainage | 1 | 1994 | 1183 | 0.000 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 1994 | 1496 | 0.000 |
Why?
|
Risk | 1 | 1998 | 9635 | 0.000 |
Why?
|
Stimulation, Chemical | 1 | 1986 | 305 | 0.000 |
Why?
|
Citrate (si)-Synthase | 1 | 1985 | 48 | 0.000 |
Why?
|
Constriction, Pathologic | 1 | 1989 | 1104 | 0.000 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1985 | 412 | 0.000 |
Why?
|
Aortography | 1 | 1986 | 422 | 0.000 |
Why?
|
Cardiac Volume | 1 | 1984 | 197 | 0.000 |
Why?
|
Angiography | 1 | 1989 | 1597 | 0.000 |
Why?
|
Creatine | 1 | 1985 | 427 | 0.000 |
Why?
|
Aorta, Abdominal | 1 | 1986 | 627 | 0.000 |
Why?
|
Child, Preschool | 1 | 1985 | 42654 | 0.000 |
Why?
|
Enzyme Activation | 2 | 1979 | 3585 | 0.000 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 1998 | 10377 | 0.000 |
Why?
|
Blood Vessel Prosthesis | 1 | 1986 | 957 | 0.000 |
Why?
|
Rabbits | 2 | 1979 | 4782 | 0.000 |
Why?
|
Nucleotidases | 1 | 1979 | 29 | 0.000 |
Why?
|
Acetylcholinesterase | 1 | 1979 | 151 | 0.000 |
Why?
|
Ouabain | 1 | 1979 | 246 | 0.000 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1985 | 1493 | 0.000 |
Why?
|
Membrane Lipids | 1 | 1979 | 251 | 0.000 |
Why?
|
Child | 1 | 1985 | 80894 | 0.000 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 1979 | 480 | 0.000 |
Why?
|
Magnesium | 1 | 1979 | 816 | 0.000 |
Why?
|
Phospholipids | 1 | 1979 | 783 | 0.000 |
Why?
|
Adenosine Triphosphatases | 1 | 1979 | 842 | 0.000 |
Why?
|
Cyclic GMP | 1 | 1975 | 394 | 0.000 |
Why?
|
Macromolecular Substances | 1 | 1975 | 1435 | 0.000 |
Why?
|
Calcium | 1 | 1985 | 5794 | 0.000 |
Why?
|
Glycoproteins | 1 | 1979 | 2204 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 1986 | 8051 | 0.000 |
Why?
|
Binding Sites | 1 | 1975 | 6018 | 0.000 |
Why?
|
Protein Binding | 1 | 1975 | 9346 | 0.000 |
Why?
|
Membrane Proteins | 1 | 1979 | 7885 | 0.000 |
Why?
|